Other P-glycoprotein inhibitors, including and ritonavir severely reduced the drug efflux and thus such co-therapy should be administered with caution while P-glycoprotein inducers (rifampin) should be avoided because it increases the risk for stroke [113]. The gene discussed is ABCB1; the disease is stroke disorder.